July 31, 2025

New Research Unit in Basic Biomedical Research

New Research Unit in Basic Biomedical Research

German Research Foundation provides approx. five million euros in funding

Heidelberg University has been successful in the most recent funding round of the German Research Foundation (DFG) with its proposal for a new DFG Research Unit in basic biomedical research. As part of this collaborative project, researchers are investigating the fundamental principles that enable organisms to adapt to changes in their environment. The Research Unit, titled “DynOrg”, involves eight other university locations and is coordinated by Prof. Dr Simon Wiegert from the Medical Faculty Mannheim. The DFG is funding the project with five million euros over a period of four years.

Porträt Simon Wiegert
Simon Wiegert | © Universitätsmedizin Mannheim

Environmental changes, such as threats from predators or heat, demand continuous adaptation. Whether physiological or behavioral, these adaptations typically occur as the result of a complex interplay between the autonomic and central nervous systems. In a threatening situation, for example, this can result in increased cardiac output and elevated levels of alertness. These adaptive responses are mediated by a small number of transmitter molecules. They act on a wide range of G protein-coupled receptors (GPCRs), which play a key role in cellular signal transduction. GPCRs are capable of coupling extracellular signals to intracellular second messenger pathways, thereby regulating many cellular processes. These receptors are the focus of the Research Unit “Dynamic Integration of GPCR Signaling Pathways for the Control of Organ Function and Animal Behavior” (DynOrg).

“Although the effects of most transmitters and the general function of specific signaling cascades are well known, we still only have a limited understanding of how GPCR signaling controls our organs and ultimately our behavior,” explains Simon Wiegert, Head of the Neurophysiology Department at the Medical Faculty Mannheim. “Our goal is therefore to investigate the fundamental principles of GPCR signaling in various animal models to better understand the principal regulatory patterns behind adaptive processes.” As the researcher notes, this interdisciplinary approach aims to generate new insights into fundamental biological questions, including organ function and disease pathologies. 

The new research network brings together experts in optogenetics, GPCR research, physiology, and pathophysiology. The consortium for the DFG-funded Research Unit was established by Prof. Wiegert in collaboration with Prof. Dr Dr Tobias Brügmann of the University Medical Center Göttingen. Simon Wiegert is a member of the Mannheim Center for Translational Neuroscience (MCTN), which offers a platform for basic researchers as well as translational and clinical neuroscientists. He is also an expert in optogenetics, a technology that uses light to precisely control the activity of nerve cells. For his research, Prof. Wiegert has already received both a Starting Grant and a Proof of Concept Grant from the European Research Council (ERC). 

Further Information

Our latest News

discover more
RHEACELL makes second location in Heidelberg visible

RHEACELL makes second location in Heidelberg visible

Heidelberg, January 28, 2026 – RHEACELL GmbH & Co. KG is continuing to expand its presence in Heidelberg and moved into a second location in the Pfaffengrund district in August last year. At the start of the year, the location is now also becoming visible to the outside world: this week, the company logo will […]

TUM Researchers receive two ERC Grants

TUM Researchers receive two ERC Grants

The European Research Council’s (ERC) Proof of Concept Grants are designed to help researchers turn their findings into real‑world innovations. Two ERC‑funded follow‑up projects at TUM will each receive approximately 150,000 euros in support. The projects focus on virus‑driven cancer treatments and new ways to supply electrons for enzyme‑based technologies. Researchers at TUM have secured […]

Weight Loss in Cancer: Organs Respond to the Disease in a Coordinated Way

Weight Loss in Cancer: Organs Respond to the Disease in a Coordinated Way

Cachexia is a metabolic disorder that causes uncontrolled weight loss and muscle wasting in chronic diseases and cancer. A new study by Helmholtz Munich, in collaboration with the Institute of Physiology of the Czech Academy of Sciences in Prague, Heidelberg University Hospital, the German Center for Diabetes Research (DZD), and the German Center for Cardiovascular […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp